2021 ISAPP共识声明:后生元的定义和范围

2021-05-04 Nat Rev Gastroenterol Hepatol.2021 May 4.

2021年5月,国际益生菌和益生元科学会(ISAPP)发布了后生元的定义和范围共识声明。文章提出了后生元的明确定义和范围。

中文标题:

2021 ISAPP共识声明:后生元的定义和范围

英文标题:

The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics

发布机构:

发布日期:

2021-05-04

简要介绍:

2021年5月,国际益生菌和益生元科学会(ISAPP)发布了后生元的定义和范围共识声明。文章提出了后生元的明确定义和范围。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=2021 ISAPP共识声明:后生元的定义和范围.pdf)] GetToolGuiderByIdResponse(projectId=1, id=445a81c0021008d9, title=2021 ISAPP共识声明:后生元的定义和范围, enTitle=The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics, guiderFrom=Nat Rev Gastroenterol Hepatol.2021 May 4., authorId=0, author=, summary=2021年5月,国际益生菌和益生元科学会(ISAPP)发布了后生元的定义和范围共识声明。文章提出了后生元的明确定义和范围。, cover=https://img.medsci.cn/2021518/1621269634360_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Tue May 04 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2021年5月,国际益生菌和益生元科学会(ISAPP)发布了后生元的定义和范围共识声明。文章提出了后生元的明确定义和范围。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=112131, tagName=后生元)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=21065, guiderKeyword=益生元, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4826, appHits=50, showAppHits=0, pcHits=1074, showPcHits=4776, likes=1, shares=6, comments=7, approvalStatus=1, publishedTime=Tue May 18 00:40:50 CST 2021, publishedTimeString=2021-05-04, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Tue May 18 00:40:42 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 05:05:47 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2021 ISAPP共识声明:后生元的定义和范围.pdf)])
2021 ISAPP共识声明:后生元的定义和范围.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=968206, encodeId=546296820682, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 24 19:04:18 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967949, encodeId=0f8296e9492f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:02:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966954, encodeId=52bd96695471, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed May 19 18:08:45 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966681, encodeId=31719666815c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/0c6ad779f9284cfaa313d6dce590b234/12b6673745a24ff5a6e5fe3d36830db8.jpg, createdBy=83165502871, createdName=ms2000002133408118, createdTime=Tue May 18 22:29:10 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966606, encodeId=8df696660630, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13395442189, createdName=ms9000000170743675, createdTime=Tue May 18 15:24:54 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-24 jyzxjiangqin

    好文章!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=968206, encodeId=546296820682, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 24 19:04:18 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967949, encodeId=0f8296e9492f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:02:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966954, encodeId=52bd96695471, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed May 19 18:08:45 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966681, encodeId=31719666815c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/0c6ad779f9284cfaa313d6dce590b234/12b6673745a24ff5a6e5fe3d36830db8.jpg, createdBy=83165502871, createdName=ms2000002133408118, createdTime=Tue May 18 22:29:10 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966606, encodeId=8df696660630, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13395442189, createdName=ms9000000170743675, createdTime=Tue May 18 15:24:54 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-23 jyzxjiangqin

    好共识!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=968206, encodeId=546296820682, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 24 19:04:18 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967949, encodeId=0f8296e9492f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:02:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966954, encodeId=52bd96695471, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed May 19 18:08:45 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966681, encodeId=31719666815c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/0c6ad779f9284cfaa313d6dce590b234/12b6673745a24ff5a6e5fe3d36830db8.jpg, createdBy=83165502871, createdName=ms2000002133408118, createdTime=Tue May 18 22:29:10 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966606, encodeId=8df696660630, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13395442189, createdName=ms9000000170743675, createdTime=Tue May 18 15:24:54 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-19 jyzxjiangqin

    好文章!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=968206, encodeId=546296820682, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 24 19:04:18 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967949, encodeId=0f8296e9492f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:02:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966954, encodeId=52bd96695471, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed May 19 18:08:45 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966681, encodeId=31719666815c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/0c6ad779f9284cfaa313d6dce590b234/12b6673745a24ff5a6e5fe3d36830db8.jpg, createdBy=83165502871, createdName=ms2000002133408118, createdTime=Tue May 18 22:29:10 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966606, encodeId=8df696660630, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13395442189, createdName=ms9000000170743675, createdTime=Tue May 18 15:24:54 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-18 ms2000002133408118

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=968206, encodeId=546296820682, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Mon May 24 19:04:18 CST 2021, time=2021-05-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=967949, encodeId=0f8296e9492f, content=好共识!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Sun May 23 17:02:32 CST 2021, time=2021-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966954, encodeId=52bd96695471, content=好文章!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160806/IMG57A5698BDB0244113.jpg, createdBy=32a91358059, createdName=jyzxjiangqin, createdTime=Wed May 19 18:08:45 CST 2021, time=2021-05-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966681, encodeId=31719666815c, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210518/0c6ad779f9284cfaa313d6dce590b234/12b6673745a24ff5a6e5fe3d36830db8.jpg, createdBy=83165502871, createdName=ms2000002133408118, createdTime=Tue May 18 22:29:10 CST 2021, time=2021-05-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=966606, encodeId=8df696660630, content=好共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=63, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=13395442189, createdName=ms9000000170743675, createdTime=Tue May 18 15:24:54 CST 2021, time=2021-05-18, status=1, ipAttribution=)]
    2021-05-18 ms9000000170743675

    好共识

    0

拓展阅读

2017 WGO全球指南:益生菌和益生元

世界胃肠病学组织(WGO,World Gastroenterology Organisation) · 2017-02-01

2023 WGO全球指南:益生菌和益生元

世界胃肠病学组织(WGO,World Gastroenterology Organisation) · 2023-02-20

2024 ESPGHAN意见书:益生元在小儿胃肠疾病治疗中的应用

欧洲儿科胃肠病学、肝病学和营养协会(ESPGHAN,European Society for Paediatric Gastroenterology, Hepatology, and Nutrition) · 2024-01-25